|
|
| 5-Day | 56,753 |
| 10-Day | 67,355 |
| 30-Day | 33,860 |
| 5-Day | 56,753 |
| 10-Day | 67,355 |
| 30-Day | 33,860 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 95.45 | 96.00 | 34 |
| 50 | 95.40 | 96.20 | 50 |
| 65 | 95.35 | 96.55 | 62 |
| 62 | 95.30 | 96.60 | 50 |
| 187 | 95.25 | 96.70 | 187 |
| 10.01 K | Total | 10.11 K | Total |
Buy Qty
10.01 K
Sell QTY
10.11 K
| 5-Day | 249,585 |
| 10-Day | 345,947 |
| 30-Day | 165,871 |
| 5-Day | 249,585 |
| 10-Day | 345,947 |
| 30-Day | 165,871 |
Announcements
Bal Pharma: Outcome of AGMAnnouncements
Bal Pharma: Outcome of board meetingAnnouncements
Bal Pharma board meeting on August 10, 2016
Top Trading Ideas
19 July 2016
buy Ceat Jul Fut |
Entry Price (Rs) 884.00 |
Exit Price (Rs) 893.00 |
Gain (Rs) 9.00 |
buy DrReddysLabs Jul Fut |
Entry Price (Rs) 3,580.00 |
Exit Price (Rs) 3,613.00 |
Gain (Rs) 33.00 |
sell Glenmark Jul Fut |
Entry Price (Rs) 847.00 |
Exit Price (Rs) 836.00 |
Gain (Rs) 11.00 |
buy BajajAuto Jul Fut |
Entry Price (Rs) 2,741.00 |
Exit Price (Rs) 2,759.00 |
Gain (Rs) 18.00 |
| Days | BSE | NSE |
| 30 | 89.70 | 89.80 |
| 50 | 92.81 | 92.95 |
| 150 | 94.66 | 94.73 |
| 200 | 100.80 | 100.80 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Bal Pharma
| Standalone | Jun'16 | Mar'16 | Dec'15 | Sep'15 |
| Net Sales | 42.92 | 53.62 | 45.38 | 54.63 |
| Other Income | 0.77 | 0.42 | 0.14 | 0.77 |
| PBDIT | 3.44 | 2.82 | 6.01 | 4.92 |
| Net Profit | 0.59 | -1.77 | 2.01 | 2.08 |
| Total Share Capital | 12.87 |
| Net Worth | 56.70 |
| Total Debt | 66.03 |
| Net Block | 55.95 |
| Investments | 1.18 |
| Total Assets | 122.71 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 781.80 | 0.22 | 933.70 | 706.40 | 188,160.02 |
| Lupin | 1487.40 | -0.09 | 2127.00 | 1294.05 | 67,092.19 |
| Dr Reddys Labs | 3201.10 | 0.63 | 4382.95 | 2750.00 | 54,667.10 |
| Aurobindo Pharm | 842.55 | 0.01 | 891.50 | 618.00 | 49,303.46 |
| Cipla | 608.50 | -0.43 | 704.75 | 458.25 | 48,936.21 |
| More » | |||||
| Dec' 15 | Sep' 15 | Jun' 15 | Mar' 15 | |
| Promoter | 48.83 | 48.83 | 48.83 | 48.83 |
| Public (FII + DII) | 51.17 | 51.17 | 51.17 | 51.17 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Exide Industries Recommended on Jul 11th 2016
Recommended price 173.00 | Peak from reco 199.50 15.15%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Bal Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 135.28 crore.
The company management includes Shailesh D Siroya - Managing Director, Subbarao Prasanna - Executive Director, Shrenik Siroya - Non Executive Director, G S R Subba Rao - Independent Director, S Pramod Kumar - Independent Director, Sarika Bhandari - Addnl. & Ind.Director.
It is listed on the BSE with a BSE Code of 524824 and the NSE with an NSE Code of BALPHARMA.
Its Registered office is at 21 & 22, Bommasandra Industrial Area,,Hosur Road Bengaluru,Karnataka - 560099.
Their Registrars are TSR Darashaw Ltd.
SET SMS ALERT
